Determinants of the sensation of thirst in terminally ill cancer patients

Supportive Care in Cancer

Volumn 9, Issue 3, 2001, Pages 177-186

  Morita, Tatsuya ^a   Tie, Y ^a   Tsunoda, J ^a   Inoue, S ^a   Chihara, S ^a  

^a Seirei Mikatabara Hospital   (Japan)

Author keywords

Dehydration; Etiology; Neoplasms; Palliative care; Thirst

Indexed keywords

ALBUMIN; ANTIDEPRESSANT AGENT; AZOSEMIDE; BUPRENORPHINE; CALCIUM; CODEINE; CREATININE; DICLOFENAC; FENTANYL; FLURBIPROFEN AXETIL; FUROSEMIDE; HALOPERIDOL; INDOMETACIN; LOXOPROFEN; MEFENAMIC ACID; MOFEZOLAC; MORPHINE; NAPROXEN; PENTAZOCINE; POTASSIUM; PROTEIN; SCOPOLAMINE BUTYL BROMIDE; SODIUM; SPIRONOLACTONE; TIMEPIDIUM BROMIDE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEROSMOLALITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STOMATITIS; TERMINAL DISEASE; THIRST;

AGED; CROSS-SECTIONAL STUDIES; DEHYDRATION; FEMALE; FLUID THERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OSMOLAR CONCENTRATION; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX; TERMINAL CARE; TERMINALLY ILL; THIRST;

EID: 0342960840     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200000205     Document Type: Article

References (38)

1. Anderson F, Downing GM, Hill J (1996) Palliative Performance Scale (PPS): a new tool. J Palliat Care 12:5-11
2. Andrews M, Bell ER, Smith SA, Tischler J, Veglia JM (1993) Dehydration in terminally ill patients. Is it appropriate palliative care? Postgrad Med 93:201-208
3. Billings JA (1985) Comfort measures for the terminally ill. Is dehydration painful? J Am Geriatr 33:808-810
4. Bozzetti F (1996) Guidelines on artificial nutrition versus hydration in terminal cancer patients. Nutrition 12:163-167
5. Burge FI (1993) Dehydration symptoms of palliative care cancer patients. J Pain Symptom Manage 8:454-464
6. Burrell LM, Lambert HJ, Baylis PH (1991) Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans. Am J Physiol R475-479
7. Burrell LM, Palmer JM, Baylis PH (1992) Atrial natriuretic peptide inhibits fluid intake in hyperosmolar subjects. Clin Sci 83:35-39
8. Conill C, Verger E, Henriquez I, et al (1997) Symptom prevalence in the last week of life. J Pain Symptom Manage 14:328-331
9. Coyle N, Adelhardt J, Foley KM, Portenoy RK (1990) Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage 5:83-93
10. Curtis EB, Krech R, Walsh TD (1991) Common symptoms in patient with advanced cancer. J Palliat Care 7:25-29
11. Dumphy K, Finlay I, Rathbone G, Gilbert J, Hicks F (1995) Rehydration in palliative and terminal care: if not - why not? Palliat Med 9:221-228
12. Dunnelly S, Walsh D (1995) The symptoms of advanced cancer. Semin Oncol 22 [Suppl 3]:67-72
13. Ellershaw JE, Sutcliffe JM, Saunders CM (1995) Dehydration and the dying patient. J Pain Symptom Manage 10:192-197
14. Hama N, Nakano K, Mukoyama M, et al (1991) Fundamental and clinical evaluation of 'Shionoria ANP', human atrial natriuretic peptide IRMA kit. Clin Rep 25:455-462
15. Hanks GCW, Cherny N (1998) Opioid analgesic therapy. In: Doyle D, Hanks GCW, MacDonald N (eds) Oxford Textbook of Palliative Medicine, 2nd edn. Oxford Medical Publications, London, pp 331-355
16. Kamoi K, Ishibashi M, Yajima T (1991) Thirst and plasma levels of vasopression, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 11:195-202
17. Knepper MA, Gottschalk CW (1993) Regulation of water balance: urine concentration and dilution. In: Schrier RW, Gottschalk CW (eds) Disease of the Kidney, 6th edn. Little, Brown, Boston, pp 107-126
18. MacDonald N (1998) Ethical issues in hydration and nutrition. In: Portenoy RK, Bruera E (eds) Topics in Palliative Care, vol 2. Oxford University Press, New York, pp 153-163
19. Maltoni M, Pirovano M, Scarpi E, et al (1995) Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 75:2613-2622
20. McCann RM, Hall WJ, Grith-Juncker A (1994) Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. JAMA 272:1263-1266
21. McInerney F (1992) Provision food and fluids in terminal care: a sociological analysis. Soc Sci Med 34:1271-1276
22. Morita T, Tsunoda J, Inoue S, Chihara S (1999) Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manage 18:338-346
23. Morita T, Tsunoda J, Inoue S, Chihara S, Adachi I (1999) Three dimensions of the rehydration-dehydration problem in a palliative care setting. J Palliat Care 15:60-61
24. Musgrave CF, Opstad J (1995) The sensation of thirst in dying patients receiving IV hydration. J Palliat Care 11:17-21
25. National Council for Hospice and Specialist Palliative Care Services (1997) Artificial hydration (AH) for people who are terminally ill. Eur J Palliat Care 4:124
26. Phillips PA, Bretherton M, Risvans J, Casley D, Johnston C, Gray L (1993) Effects of drinking on thirst and vasopressin in dehydrated elderly men. Am J Physiol 264:R877-881
27. Reuben DB, Mor V, Hiris J (1988) Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148:1586-1591
28. Tan ACITL, Hoefnagels WHL, Gerristen AAJ, Jansen RWMM, Kloppenborg PWC, Benraad TJ (1991) Mild dehydration and atrial natriuretic peptide in young and elderly subjects. Horm Metab Res 23:435-137
29. Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage 12:3-10
30. Ventafridda V, DeConne F, Ripamonti C, et al (1990) Quality-of-life assessment during a palliative care program. Ann Oncol 1:415-420
31. Viola RA, Wells GA, Peterson J (1997) The effects of fluid status and fluid therapy on the dying: a systemic review. J Palliat Care 13:41-52
32. Wazna-Wesly JM, Meranda DL, Carey P, Shenker Y (1995) Effect of atrial natriuretic hormone on vasopressin and thirst response to osmotic stimulation in human subjects. J Lab Clin Med 125:734-742
33. White ID, Hoskin PJ, Hanks GW, et al (1989) Morphine and dryness of the mouth. BMJ 298:1222-1223
34. Williams TDM, Seckl JR, Lightman SL (1989) Dependent effect of drinking volume on vasopressin but not atrial peptide in humans. Am J Physiol 257:R762-764
35. Wilkins MR, Redondo J, Brown LA (1997) The natriuretic-peptide family. Lancet 349:1307-1310
36. Winaver J, Abassi Z, Green J, Skorecki KL (2000) Control of extracellular fluid volume and the pathophysiology of edema formation. In: Brenner BM (ed) The Kidney, 6th edn. Saunders, Philadelphia, pp 795-865
37. Wolfram G, Sitter T, Gottsmann M, Gerzer R, Schiffl H (1996) Assessment of dry weight in haemodialysis patients by the volume markers ANP and cGMP. Nephrol Dial Transplant 11 [Suppl 2]:28-30
38. World Health Organization (1979) Handbook for reporting results of cancer treatment. (WHO offset publication no 48) WHO, Geneva